https://arxiv.org/api/jPQ8UlVLl91qizwaJ/i2L8f6ZB0 2026-06-19T07:36:10Z 1596 555 15 http://arxiv.org/abs/2201.08176v1 2022-01-20T13:48:12Z

Prominently accountable for the upsurge of COVID-19 cases as the world attempts to recover from the previous two waves, Omicron has further threatened the conventional therapeutic approaches. Omicron is the fifth variant of concern (VOC), which comprises more than 10 mutations in the receptor-binding domain (RBD) of the spike protein. However, the lack of extensive research regarding Omicron has raised the need to establish correlations to understand this variant by structural comparisons. Here, we evaluate, correlate, and compare its genomic sequences through an immunoinformatic approach with wild and mutant RBD forms of the spike protein to understand its epidemiological characteristics and responses towards existing drugs for better patient management. Our computational analyses provided insights into infectious and pathogenic trails of the Omicron variant. In addition, while the analysis represented South Africa's Omicron variant being similar to the highly-infectious B.1.620 variant, mutations within the prominent proteins are hypothesized to alter its pathogenicity. Moreover, docking evaluations revealed significant differences in binding affinity with human receptors, ACE2 and NRP1. Owing to its characteristics of rendering existing treatments ineffective, we evaluated the drug efficacy against their target protein encoded in the Omicron through molecular docking approach. Most of the tested drugs were proven to be effective. Nirmatrelvir (Paxlovid), MPro 13b, and Lopinavir displayed increased effectiveness and efficacy, while Ivermectin showed the best result against Omicron.

2022-01-20T13:48:12Z 30 pages, 5 figures Immunity, Inflammation and Disease 10 (2022), e639 Md Sorwer Alam Parvez Manash Kumar Saha Md. Ibrahim Yusha Araf Md. Taufiqul Islam Gen Ohtsuki Mohammad Jakir Hosen 10.1002/iid3.639 http://arxiv.org/abs/2201.07233v1 2022-01-18T18:14:02Z

Neuroinflammation is a significant aspect of many neurological diseases of Homo sapiens, and the genes that are differentially expressed in this process should be well understood to gather the nature of such diseases. We have conducted a meta-analysis (based on a combined adjusted P value and logFC scheme) of 6 multi-species (Homo sapiens, Mus musculus) datasets (available on GEO, short for Gene Expression Omnibus) obtained through microarray technology. Our analysis shows that the genes coding pleckstrin homology domain and galectin-9 proteins take part in neuroinflammation in microglia.

2022-01-18T18:14:02Z 6 pages, 2 tables Berk C. Ugurdag Serena Aktürk Michelle Adams http://arxiv.org/abs/2201.04296v1 2022-01-12T04:38:41Z

The present study evaluated In vitro effect of gentamicin sulfate and ceftiofur sodium on the viability of the Marek's disease virus. The titer of cell associated turkey herpesvirus (HVT) vaccine was not appreciably reduced when incubated with 50 mg/ml of gentamicin sulfate or ceftiofur sodium. Statistic difference was not found between the number of plaqueforming units (PFU) of reconstituted vaccine associated with both antibiotics 0, 15, 30 and 60 minutes after reconstitution of vaccine. The antibiotics did not considerably alter the pH values. There was a significative decrease of the titer of all vaccinal solutions when they were inoculated 30 and 60 minutes after the reconstitution of the vaccine. Nevertheless, these titers are higher than the required titers to protectect against the Marek disease.

2022-01-12T04:38:41Z in Spanish Proceedings of the XX Latin American Poultry Congress. 2007. Porto Alegre, Brazil J. Chacon M. Pimentel A. Pedroso A. Ferreira D. Martinez C. Ruelas http://arxiv.org/abs/2201.04289v1 2022-01-12T03:45:03Z

The objective of this study was to determine the effect of feeding an antimicrobial association to males broiler chickens from 0 to 14 days of age on the performance and clinical signs of bacterial processes. Two treatments were tested: a control treatment without Respirend-M, and a treatment with the antimicrobial (300 g/t Respirend-M, 0-14 d). 398 male Cobb 500 chicks were randomly assigned to two treatments and four replications per treatment. Body weight at 14 d, body weight gain, feed intake, feed conversion ratio, and health status were evaluated. The results showed feeding 300 g/t Respirend-M significantly (P<0.05) improved the final body weight, the body weight gain and the feed intake. No statistically significant (P>0.05) effect was detected on the feed conversion ratio.

2022-01-12T03:45:03Z in Spanish Proceedings of the III AMEVEA-Peru International Seminar and I Scientific Meeting. 2005. Lima, Peru Mario Chuy Marcial Cumpa Diego Martinez http://arxiv.org/abs/2201.04282v1 2022-01-12T03:26:00Z

An experiment was conducted to evaluate the effect of feeding post-weaned piglets different levels of a commercial amoxicillin plus norfloxacin formula (Respirend) on the performance, clinical evidence of sickness, and the cost:benefit ratio. 454 PIC x Camborough female and castrated male, weaned at 21 d of age, with an average initial weight of 6.19 kg, were used in this experiment. Treatment 1 consisted in feeding a basal diet supplemented with 1000 g of a commercial tilmicosin product (Pulmotil) per metric tonne of feed (control group, from 21 to 35 d of age) and Treatments 2), 3) and 4) consisted in feeding the basal diet supplement with 500, 300 y 100 g of Respirend per metric tonne of feed, respectively, from 21 to 42 d of age. The results did not show significant differences (P<0.05) in mortality nor in parenteral medicine administration cost in none of the periods. Nevertheless, 500 g of Respirend per metric tonne of feed improved significantly (P<0.05) the general health status in the period between 21 and 35 d of age. For the whole evaluation period (21 to 42 d of age), this level improved significantly (P<0.05) the final body weight, the average daily weight gain, the average daily feed intake, the feed:gain ratio and optimized the cost:benefit ratio.

2022-01-12T03:26:00Z in Spanish Anales Cientificos 2003 55(May-Aug): 141-149 Diego Martinez Enrique Alvarado Carlos Vilchez http://arxiv.org/abs/2201.11849v1 2022-01-11T11:43:13Z

Our understanding of radiation induced cellular damage has greatly improved over the past decades. Despite this progress, there are still many obstacles to fully understanding how radiation interacts with biologically relevant cellular components to form observable endpoints. One hurdle is the difficulty faced by members of different research groups in directly comparing results. Multiple Monte Carlo codes have been developed to simulate damage induction at the DNA scale, while at the same time various groups have developed models that describe DNA repair processes with varying levels of detail. These repair models are intrinsically linked to the damage model employed in their development, making it difficult to disentangle systematic effects in either part of the modelling chain. The modelling chain typically consists of track structure Monte Carlo simulations of the physics interactions creating direct damages to the DNA; followed by simulations of the production and initial reactions of chemical species causing indirect damages. After the DNA damage induction, DNA repair models combine the simulated damage patterns with biological models to determine the biological consequences of the damage. We propose a new Standard data format for DNA Damage to unify the interface between the simulation of damage induction and the biological modelling of cell repair processes. Such a standard greatly facilitates inter model comparisons, providing an ideal environment to tease out model assumptions and identify persistent, underlying mechanisms. Through inter model comparisons, this unified standard has the potential to greatly advance our understanding of the underlying mechanisms of radiation induced DNA damage and the resulting observable biological effects.

2022-01-11T11:43:13Z Radiation Research, 191(1): 76-92 J. Schuemann A. McNamara J. W. Warmenhoven N. T. Henthorn K. Kirkby M. J. Merchant S. Ingram H. Paganetti KD. Held J. Ramos-Mendez B. Faddegon J. Perl D. Goodhead I. Plante H. Rabus H. Nettelbeck W. Friedland P. Kundrat A. Ottolenghi G. Baiocco S. Barbieri M. Dingfelder S. Incerti C. Villagrasa M. Bueno M. A. Bernal S. Guatelli D. Sakata J. M. C. Brown Z. Francis I. Kyriakou N. Lampe F. Ballarini M. P. Ca-rante M. Davidkova V. Štepán X. Jia F. A. Cucinotta R. Schulte R. Stewart D. Carlson S. Galer Z. Kuncic S. LaCombe J. Milligan S. H. Cho T. Inaniwa T. Sato M Durante K Prise S. J. McMahon 10.1667/RR15209.1 http://arxiv.org/abs/2111.01282v2 2022-01-05T22:41:05Z

I present here longitudinal evaluation of T and B cell immunity to SARS-CoV2 and variants of concern (VOC) from a single subject (me) over an entire year post vaccination. After enrolling in the Moderna phase III clinical trial, I collected my own biological samples pre- and post-immunization in the event of being a recipient of the experimental vaccine. The evidence strongly supports the conclusion that I did not receive the placebo. The analysis is admittedly limited to an n of 1, but the results fit well with data taken from published works and represent one of the more comprehensive longitudinal evaluations of vaccine-elicited immunity within a single individual yet to be undertaken. Though the data amount to a well-documented anecdote, given its granularity, it is not without its insights and may be of further use in directing future longitudinal studies that have actual statistical significance.

2021-11-01T22:19:40Z Ross M. Kedl http://arxiv.org/abs/2201.07162v1 2021-12-30T02:47:35Z

We describe some properties of the evolution of the COVID-19 pandemic that reveal its behavior as a complex system. The propagation mechanism shows a Poincare section with fractal dimension 1 <D <2. The present period of apparent recovery shows a relaxation with non-extensive statistical properties.

2021-12-30T02:47:35Z Submitted for publication, 22 pages, in Spanish, 12 figures Oscar Sotolongo-Costa Fernando Guzman Martinez http://arxiv.org/abs/2112.14548v1 2021-12-29T13:42:36Z

Background: Calculation of the electric field induced by transcranial magnetic stimulation (TMS) in the brain requires accurate models of the stimulation coils. Reconstructing models from the measured magnetic fields of coils so far worked only for flat coil geometries and required data of their full magnetic field distribution. Objective: To reconstruct models of coils with arbitrary winding geometries from spatially incomplete magnetic field measurements. Methods: Dipole approximation via minimum norm estimation with a cross validation procedure simultaneously assessing predictability and reproducibility of the field approximation. The methods were validated on both simulated and acquired magnetic flux density data. Furthermore, reconstruction of coil models from sparsely sampled data is investigated and a procedure for obtaining sparse dipole coil models based on orthogonal matching pursuit is suggested. Results: Given that measured data from regions around the coil are available, the magnetic vector potential can accurately be represented by fitted dipole models even from sparsely sampled data. Considerable sparsification of dipole models is possible while retaining accurate representation of the field also close to the coil. Conclusion: Our versatile approach removes an important hurdle for constructing coil models from measurement data and enables a flexible trade-off between the accuracy and computational efficiency of the reconstructed dipole models.

2021-12-29T13:42:36Z Kristoffer Hougaard Madsen Maria Drakaki Axel Thielscher http://arxiv.org/abs/2112.12791v1 2021-12-22T21:05:24Z

Animal-related outages (AROs) are a prevalent form of outages in electrical distribution systems. Animal-infrastructure interactions vary across focal species and regions, underlining the need to study the animal-outage relationship in more species and diverse systems. Animal activity has been used as an indicator of reliability in the electrical grid system and to describe temporal patterns in AROs. However, these ARO models have been limited by a lack of available estimates of species activity, instead approximating activity based on seasonal and weather patterns in animal-related outage records and characteristics of broad taxonomic groups, e.g., squirrels. We highlight publicly available resources to fill the ecological data gap that is limiting joint analyses between ecology and energy sectors. Species distribution models (SDMs), a common technique to model the distribution of a species across geographic space and time, paired with data sourced from eBird, a community science database for bird observations, provided us with species-specific estimates of activity to model spatio-temporal patterns of AROs. These flexible, species-specific estimates can allow future animal-indicators of grid reliability to be investigated in more diverse regions and ecological communities, providing a better understanding of the variation that exists in animal-outage relationship. AROs were best modeled by accounting for multiple outage-prone species activity patterns and their unique relationships with seasonality and habitat availability. Different species were important for modeling outages in different landscapes and seasons depending on their distribution and migration behavior. We recommend that future models of AROs include species-specific activity data that account for the diverse spectrum of spatio-temporal activity patterns that outage-prone animals exhibit.

2021-12-22T21:05:24Z Mei-Ling E. Feng Olukunle O. Owolabi Toryn L. J. Schafer Sanhita Sengupta Lan Wang David S. Matteson Judy P. Che-Castaldo Deborah A. Sunter http://arxiv.org/abs/2112.12554v1 2021-12-22T05:33:15Z

Human space exploration beyond low Earth orbit will involve missions of significant distance and duration. To effectively mitigate myriad space health hazards, paradigm shifts in data and space health systems are necessary to enable Earth-independence, rather than Earth-reliance. Promising developments in the fields of artificial intelligence and machine learning for biology and health can address these needs. We propose an appropriately autonomous and intelligent Precision Space Health system that will monitor, aggregate, and assess biomedical statuses; analyze and predict personalized adverse health outcomes; adapt and respond to newly accumulated data; and provide preventive, actionable, and timely insights to individual deep space crew members and iterative decision support to their crew medical officer. Here we present a summary of recommendations from a workshop organized by the National Aeronautics and Space Administration, on future applications of artificial intelligence in space biology and health. In the next decade, biomonitoring technology, biomarker science, spacecraft hardware, intelligent software, and streamlined data management must mature and be woven together into a Precision Space Health system to enable humanity to thrive in deep space.

2021-12-22T05:33:15Z 31 pages, 4 figures Ryan T. Scott KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Erik L. Antonsen Department of Emergency Medicine, Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA Lauren M. Sanders Blue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Jaden J. A. Hastings Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA Seung-min Park Department of Urology, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA Graham Mackintosh Bay Area Environmental Research Institute, NASA Ames Research Center, Moffett Field, CA, USA Robert J. Reynolds Mortality Research & Consulting, Inc., Houston, TX, USA Adrienne L. Hoarfrost Universities Space Research Association Aenor Sawyer UC Space Health, Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA Casey S. Greene Center for Health AI, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA Benjamin S. Glicksberg Hasso Plattner Institute for Digital Health at Mount Sinai, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA Corey A. Theriot Department of Preventive Medicine and Community Health, UTMB, Galveston, TX, USA Human Health and Performance Directorate, NASA Johnson Space Center, Houston, TX, USA Daniel C. Berrios KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Jack Miller KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Joel Babdor Department of Microbiology and Immunology, Department of Otolaryngology, Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA Richard Barker The Gilroy AstroBiology Research Group, The University of Wisconsin, Madison, Madison, WI, USA Sergio E. Baranzini Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA Afshin Beheshti KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Stuart Chalk Department of Chemistry, University of North Florida, Jacksonville, FL, USA Guillermo M. Delgado-Aparicio Data Science Analytics, Georgia Institute of Technology, Lima, Peru Melissa Haendel Center for Health AI, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA Arif A. Hamid Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA Philip Heller Department of Computer Science, College of Science, San José State University, San Jose, CA, USA Daniel Jamieson Biorelate, Manchester, United Kingdom Katelyn J. Jarvis UC Space Health, Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA John Kalantari Center for Individualized Medicine, Department of Surgery, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA Kia Khezeli Center for Individualized Medicine, Department of Surgery, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA Svetlana V. Komarova Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada Matthieu Komorowski Faculty of Medicine, Department of Surgery and Cancer, Imperial College London, London, United Kingdom Prachi Kothiyal SymbioSeq LLC, NASA Johnson Space Center, Ashburn, VA, USA Ashish Mahabal Center for Data Driven Discovery, California Institute of Technology, Pasadena, CA, USA Uri Manor Waitt Advanced Biophotonics Center, Chan-Zuckerberg Imaging Scientist Fellow, Salk Institute for Biological Studies, La Jolla, CA, USA Hector Garcia Martin Biological Systems and Engineering Division, Lawrence Berkeley National Lab, Berkeley, CA, USA DOE Agile BioFoundry, Emeryville, CA, USA Joint BioEnergy Institute, Emeryville, CA, USA Christopher E. Mason Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA Mona Matar Human Research Program Cross-cutting Computational Modeling Project, NASA John H. Glenn Research Center, Cleveland, OH, USA George I. Mias Institute for Quantitative Health Science and Engineering, Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA Jerry G. Myers, Human Research Program Cross-cutting Computational Modeling Project, NASA John H. Glenn Research Center, Cleveland, OH, USA Charlotte Nelson Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA Jonathan Oribello Blue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Patricia Parsons-Wingerter Low Exploration Gravity Technology, NASA John H. Glenn Research Center, Cleveland, OH, USA R. K. Prabhu Universities Space Research Association Amina Ann Qutub AI MATRIX Consortium, Department of Biomedical Engineering, University of Texas, San Antonio and UT Health Sciences, San Antonio, TX, USA Jon Rask Office of the Center Director, NASA Ames Research Center, Moffett Field, CA, USA Amanda Saravia-Butler Logyx, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Suchi Saria Computer Science, Statistics, and Health Policy, Johns Hopkins University, Baltimore, MD, USA ML, AI and Healthcare Lab, Bayesian Health, New York, NY, USA Nitin Kumar Singh Biotechnology and Planetary Protection Group, Jet Propulsion Laboratory, Pasadena, CA, USA Frank Soboczenski SPHES, Medical Faculty, King's College London, London, United Kingdom Michael Snyder Department of Genetics, Stanford School of Medicine, Stanford, CA, USA Karthik Soman Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA David Van Valen Department of Biology, California Institute of Technology, Pasadena, CA, USA Kasthuri Venkateswaran Biotechnology and Planetary Protection Group, Jet Propulsion Laboratory, Pasadena, CA, USA Liz Warren ISS National Laboratory, Center for the Advancement of Science in Space, Melbourne, FL, USA Liz Worthey UAB Center for Computational Biology and Data Science, University of Alabama, Birmingham, Birmingham, AL, USA Jason H. Yang Center for Emerging and Re-Emerging Pathogens, Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA Marinka Zitnik Department of Biomedical Informatics, Harvard Medical School, Harvard Data Science, Broad Institute of MIT and Harvard, Harvard University, Boston, MA, USA Sylvain V. Costes Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA http://arxiv.org/abs/2112.12582v1 2021-12-22T05:18:26Z

Space biology research aims to understand fundamental effects of spaceflight on organisms, develop foundational knowledge to support deep space exploration, and ultimately bioengineer spacecraft and habitats to stabilize the ecosystem of plants, crops, microbes, animals, and humans for sustained multi-planetary life. To advance these aims, the field leverages experiments, platforms, data, and model organisms from both spaceborne and ground-analog studies. As research is extended beyond low Earth orbit, experiments and platforms must be maximally autonomous, light, agile, and intelligent to expedite knowledge discovery. Here we present a summary of recommendations from a workshop organized by the National Aeronautics and Space Administration on artificial intelligence, machine learning, and modeling applications which offer key solutions toward these space biology challenges. In the next decade, the synthesis of artificial intelligence into the field of space biology will deepen the biological understanding of spaceflight effects, facilitate predictive modeling and analytics, support maximally autonomous and reproducible experiments, and efficiently manage spaceborne data and metadata, all with the goal to enable life to thrive in deep space.

2021-12-22T05:18:26Z 28 pages, 4 figures Lauren M. Sanders Blue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Jason H. Yang Center for Emerging and Re-Emerging Pathogens, Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ, USA Ryan T. Scott KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Amina Ann Qutub AI MATRIX Consortium, Department of Biomedical Engineering, University of Texas, San Antonio and UT Health Sciences, San Antonio, TX, USA Hector Garcia Martin Biological Systems and Engineering Division, Lawrence Berkeley National Lab, Berkeley, CA, USA DOE Agile BioFoundry, Emeryville, CA, USA Joint BioEnergy Institute, Emeryville, CA, USA Daniel C. Berrios KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Jaden J. A. Hastings Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA Jon Rask Office of the Center Director, NASA Ames Research Center, Moffett Field, CA, USA Graham Mackintosh Bay Area Environmental Research Institute, NASA Ames Research Center, Moffett Field, CA, USA Adrienne L. Hoarfrost Universities Space Research Association Stuart Chalk Department of Chemistry, University of North Florida, Jacksonville, FL, USA John Kalantari Center for Individualized Medicine, Department of Surgery, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA Kia Khezeli Center for Individualized Medicine, Department of Surgery, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA Erik L. Antonsen Department of Emergency Medicine, Center for Space Medicine, Baylor College of Medicine, Houston, TX, USA Joel Babdor Department of Microbiology and Immunology, Department of Otolaryngology, Head and Neck Surgery, University of California San Francisco, San Francisco, CA, USA Richard Barker The Gilroy AstroBiology Research Group, The University of Wisconsin - Madison, Madison, WI, USA Sergio E. Baranzini Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA Afshin Beheshti KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Guillermo M. Delgado-Aparicio Data Science Analytics, Georgia Institute of Technology, Lima, Peru Benjamin S. Glicksberg Hasso Plattner Institute for Digital Health at Mount Sinai, Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA Casey S. Greene Center for Health AI, Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA Melissa Haendel Center for Health AI, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, CO, USA Arif A. Hamid Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA Philip Heller Department of Computer Science, College of Science, San José State University, San Jose, CA, USA Daniel Jamieson Biorelate, Manchester, United Kingdom Katelyn J. Jarvis UC Space Health, Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA Svetlana V. Komarova Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada Matthieu Komorowski Faculty of Medicine, Dept of Surgery and Cancer, Imperial College London, London, United Kingdom Prachi Kothiyal SymbioSeq LLC, NASA Johnson Space Center, Ashburn, VA, USA Ashish Mahabal Center for Data Driven Discovery, California Institute of Technology, Pasadena, CA, USA Uri Manor Waitt Advanced Biophotonics Center, Chan-Zuckerberg Imaging Scientist Fellow, Salk Institute for Biological Studies, La Jolla, CA, USA Christopher E. Mason Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA Mona Matar Human Research Program Cross Cutting Computational Modeling Project, NASA John H. Glenn Research Center, Cleveland, OH, USA George I. Mias Institute for Quantitative Health Science and Engineering, Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA Jack Miller KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Jerry G. Myers Human Research Program Cross Cutting Computational Modeling Project, NASA John H. Glenn Research Center, Cleveland, OH, USA Charlotte Nelson Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA Jonathan Oribello Blue Marble Space Institute of Science, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Seung-min Park Department of Urology, Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA Patricia Parsons-Wingerter Low Exploration Gravity Technology, NASA John H. Glenn Research Center, Cleveland, OH, USA R. K. Prabhu Universities Space Research Association Robert J. Reynolds Mortality Research & Consulting, Inc., Houston, TX, USA Amanda Saravia-Butler Logyx, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA Suchi Saria Computer Science, Statistics, and Health Policy, Johns Hopkins University, Baltimore, MD, USA ML, AI and Healthcare Lab, Bayesian Health, New York, NY, USA Aenor Sawyer Biorelate, Manchester, United Kingdom Nitin Kumar Singh Biotechnology and Planetary Protection Group, Jet Propulsion Laboratory, Pasadena, CA, USA Frank Soboczenski SPHES, Medical Faculty, King's College London, London, United Kingdom Michael Snyder Department of Genetics, Stanford School of Medicine, Stanford, CA USA Karthik Soman Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA Corey A. Theriot Department of Preventive Medicine and Community Health, UTMB, Galveston, TX USA Human Health and Performance Directorate, NASA Johnson Space Center, Houston, TX, USA David Van Valen Department of Biology, California Institute of Technology, Pasadena, CA, USA Kasthuri Venkateswaran Biotechnology and Planetary Protection Group, Jet Propulsion Laboratory, Pasadena, CA, USA Liz Warren ISS National Laboratory, Center for the Advancement of Science in Space, Melbourne, FL, USA Liz Worthey UAB Center for Computational Biology and Data Science, University of Alabama, Birmingham, Birmingham, AL, USA Marinka Zitnik Department of Biomedical Informatics, Harvard Medical School, Harvard Data Science, Broad Institute of MIT and Harvard, Harvard University, Boston, MA, USA Sylvain V. Costes Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA http://arxiv.org/abs/2112.12550v1 2021-12-21T16:01:37Z

Statistical mechanics has grown without bounds in space. Statistical mechanics of point particles in an unbounded perfect gas is commonly accepted as a foundation for understanding many systems, including liquids like the concentrated salt solutions of life and electrochemical technology, from batteries to nanodevices. Liquids, however, are not gases. Liquids are filled with interacting molecules and so the model of a perfect gas is imperfect. Here we show that statistical mechanics without bounds (in space) is impossible as well as imperfect, if the molecules interact as charged particles, as nearly all atoms do. The behavior of charged particles is not defined until boundary structures and values are defined because charges are governed by the Maxwell partial differential equations. Partial differential equations require boundary conditions to be computable or well defined. The Maxwell equations require boundary conditions on finite sized spatial boundaries (i.e., structures). Boundary conditions cannot be defined 'at infinity' in a general (i.e., unique) way because the limiting process that defines infinity includes such a wide variety of behavior, from light waves that never decay, to fields from dipole and multipolar charges that decay steeply, to Coulomb fields that decay but not so steeply. Statistical mechanics involving charges thus involves spatial boundaries and boundary conditions of finite size. Nearly all matter involves charges, thus nearly all statistical mechanics requires structures and boundary conditions on those structures. Boundaries and boundary conditions are not prominent in classical statistical mechanics. Including boundaries is a challenge to mathematicians. Statistical mechanics must describe bounded systems if it is to provide a proper foundation for studying matter.

2021-12-21T16:01:37Z Bob Eisenberg http://arxiv.org/abs/2112.09417v1 2021-12-17T10:25:00Z

DNA Data storage has recently attracted much attention due to its durable preservation and extremely high information density (bits per gram) properties. In this work, we propose a hybrid coding strategy comprising of generalized constrained codes to tackle homopolymer (run-length) limit and a protograph based low-density parity-check (LDPC) code to correct asymmetric nucleotide level (i.e., A/T/C/G) substitution errors that may occur in the process of DNA sequencing. Two sequencing techniques namely, Nanopore sequencer and Illumina sequencer with their equivalent channel models and capacities are analyzed. A coding architecture is proposed to potentially eliminate the catastrophic errors caused by the error-propagation in the constrained decoding while enabling high coding potential. We also show the log likelihood ratio (LLR) calculation method for the belief propagation decoding with this coding architecture. The simulation results and the theoretical analysis show that the proposed coding scheme exhibits good bit-error rate (BER) performance and high coding potential ($\sim1.98$ bits per nucleotide).

2021-12-17T10:25:00Z Yixin Wang Li Deng Md. Noor-A-Rahim Erry Gunawan Yong L. Guan Zhi P. Shi Chueh L. Poh http://arxiv.org/abs/2112.06923v2 2021-12-15T07:10:09Z

Life has a special status, it even has its own science: biology. In many ways, the logic of life seems to differ from that of atoms, molecules, planets, or any other `inanimate object'. However, life is increasingly measured using quantities shared by all sciences, like mass, force, energy or power. An analysis of the dimensions of these quantities provides powerful ways to infer the relationships they might have with one another. Here we show that a dimensional analysis of the metabolic laws connecting the characteristic powers and masses of living organisms offers new ways to understand the deep connections between the chemistry of microscopic molecules and the physics of macroscopic objects bound by gravity. This analysis reveals a link between metabolism and the cascades of energy observed in turbulent flows, opening new perspectives for both fields.

2021-12-13T14:35:30Z 7 pages, 2 figures Marc-Antoine Fardin